Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Vietnam flag Vietnam · Delayed Price · Currency is VND
53,000
0.00 (0.00%)
At close: Apr 28, 2026
Market Cap1.17T +58.2%
Revenue (ttm)971.25B +4.3%
Net Income61.59B -11.2%
EPS2,788.97
Shares Out22.08M
PE Ratio19.00
Forward PEn/a
Dividend2,500.00 (4.72%)
Ex-Dividend Daten/a
Volume157
Average Volume4,387
Open53,000
Previous Closen/a
Day's Range53,000 - 53,000
52-Week Range34,000 - 60,500
Beta-0.19
RSI45.59
Earnings DateJul 17, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products in Vietnam. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamins, minerals, antiseptics, and others. The company also engages in the hotel and real estate businesses; and provision of drug storage and testing, and technology transfer consulting services. I... [Read more]

Industry Pharmaceutical Preparations
Founded 2003
Employees 195
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol VDP
Full Company Profile

Financial Performance

In 2025, HOSE:VDP's revenue was 985.64 billion, an increase of 5.47% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.

Financial Statements